Explainer

Do peptides penetrate skin? What permeation studies show

Prepared by: Research Desk. Sources are linked for verification.

"Do peptides penetrate skin?" is probably the most important question in cosmetic peptide science. It is also the one product marketing answers least clearly. An ingredient can produce striking results on skin cells in a dish. That tells us very little about what happens when it sits on intact facial skin. Its activity only matters there if enough of it crosses the outer barrier.

This lab note sets out the physical problem and what laboratory permeation studies measure. It explains why a human study that reports visible changes is not the same as a study showing where a peptide went. It closes with the research on carriers and enhancers, and why "deep penetration" wording is also a regulatory matter. For the wider family overview, see our lab notebook guide to peptides in skincare.

Lab note: the short answer

The honest summary is "some, sometimes, and it depends heavily on the molecule and the formula."

Most cosmetic peptides are larger than the size range that passes easily through intact skin. Many are also water-loving, which works against crossing the oily outer layer. Permeation data exist for a few well-known ingredients, but they come mostly from laboratory models. The human studies mostly measure surface outcomes such as wrinkle grading, not how deep the peptide reached.

Observation 1: the barrier and the 500 Dalton rule

The outermost layer of skin, the stratum corneum, is a compact layer of flattened dead cells set in lipids. It exists to keep water in and outside substances out, and it does that job well.

In 2000, Bos and colleagues published a widely cited rule of thumb called the "500 Dalton rule" [1]. A Dalton (Da) is a unit of molecular mass. The authors observed that common contact allergens, and the compounds used successfully in topical and transdermal products, fell below about 500 Da. They argued that molecules much larger than this generally do not pass through intact skin in meaningful amounts [1].

Two caveats belong in every lab notebook entry about this rule:

  • It is a heuristic, not a law of physics. It was derived from patterns across known compounds, not from a sharp measured cut-off [1].

  • Size is not the only variable. Fat versus water solubility, charge and the vehicle the molecule is dissolved in all affect how a compound behaves on skin.

Observation 2: where cosmetic peptides sit

A peptide is a chain of amino acids, and each added amino acid increases the mass. Even short cosmetic peptides of four to six amino acids tend to land above the 500 Da guideline. Once a modifying group is attached, most sit well above it.

Formulators often attach a fatty-acid chain to a peptide (the palmitoyl- prefix) or cap one end (acetyl-). These changes are intended to make the molecule more compatible with skin lipids and more stable. But adding a palmitoyl chain also adds mass, so it moves the molecule further from the size guideline even as it changes its solubility.

The practical consequence for anyone reading labels: whether a given modification produces meaningful penetration has to be tested ingredient by ingredient, in a specific vehicle. It cannot be assumed from the prefix alone.

Observation 3: what permeation studies measure

Permeation research usually uses laboratory set-ups rather than living people. Typical models include excised human or animal skin, or synthetic membranes, mounted in diffusion cells. Researchers then measure how much of the compound appears in the different skin layers or passes through into a receiving fluid over time. The review by Hmingthansanga and colleagues describes this family of topical-delivery research, along with the strategies used to change permeation [4].

Zdrada-Nowak and colleagues' 2025 review focuses on one ingredient, acetyl hexapeptide-8, a neurotransmitter-inhibiting peptide. It gathers both its skin permeability data and its efficacy data [2]. The review's framing is the key point for this note. It describes the molecule's size and hydrophilic (water-loving) character as obstacles to crossing the stratum corneum, and much of the work it summarises looks at ways formulation might change permeation [2]. A finding that some peptide reaches upper skin layers in a laboratory model is not a direct measure of how much reaches living target cells in everyday use.

What these models can and cannot show:

Evidence type

What it measures

What it cannot show on its own

Cell culture study

Effect of a peptide applied directly to cells

Whether the peptide reaches those cells through intact skin

Laboratory permeation study (excised skin or membrane)

How much compound enters or crosses skin layers under test conditions

Real-world effects on the appearance of living skin

Human study of surface outcomes

Wrinkle grading, imaging, hydration or texture measures

Where the peptide went or at what concentration

Review article

Patterns and gaps across studies

New data; quality depends on the studies reviewed

Observation 4: a human study measures the surface, not the depth

The best-known human study in this area is Robinson and colleagues' 2005 study of palmitoyl pentapeptide-4 on photoaged facial skin [3]. It was a 12-week, double-blind, vehicle-controlled, split-face study in 93 women. Each participant applied the peptide formula to one side of the face and a vehicle without the peptide to the other. Using image analysis and expert grading, the authors reported measurable differences in fine lines and wrinkles on the peptide side compared with the vehicle side [3].

The design is a useful one. The split-face, vehicle-controlled set-up reduces many sources of bias. But note what the study measured. It assessed the skin's surface appearance. It did not measure how deeply the peptide travelled or what concentration reached the dermis. A surface result is consistent with some penetration, but on its own it does not establish the route or the depth. It also concerns one ingredient in one formula, and the results cannot be carried over to every product that contains a peptide.

Observation 5: carriers and enhancers in the research literature

Because the barrier is so effective, delivery science has developed several ways to move larger molecules into skin. The approaches below come from the general topical and transdermal research literature. Most of this work was not done specifically on cosmetic peptides:

  • Chemical permeation enhancers. These are ingredients that temporarily disturb the packing of stratum corneum lipids. Hmingthansanga and colleagues review them alongside newer advanced approaches [4].

  • Transfersomes. These are highly deformable lipid vesicles, proposed to squeeze through gaps in the stratum corneum. Benson's review covers their design and the delivery data reported for them [5].

  • Ethosomes. These are lipid vesicles with a high ethanol content. Hameed and colleagues review them as a nanovesicular carrier intended to get past skin barriers [6].

  • Microneedles. These are arrays of tiny projections that create microchannels in the outer skin layer. Khare and colleagues review them as a physical method of enhancing penetration [7]. They work by physically breaching the barrier, which puts them in a different category from a conventional topical serum.

For readers comparing labels, the takeaway is simple. A carrier technology described in the research literature is not evidence that a particular product's version of it delivers a particular peptide. That would need its own permeation data.

Observation 6: why "deep penetration" claims are also a regulatory issue

Under U.S. law, whether a product counts as a cosmetic or a drug depends on its intended use, as shown in its claims. Cosmetics are intended to cleanse, beautify, promote attractiveness or alter the appearance. Products intended to affect the structure or any function of the body fall into the drug category [8]. Marketing that says a peptide penetrates deep into skin to change its structure is therefore more than a science question. It is also the kind of wording the cosmetic/drug distinction turns on.

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) added duties for cosmetic companies. These include facility registration, product listing, adverse event reporting and safety substantiation [9]. Our regulatory explainer on peptide serums walks through what these changes mean for reading a product claim.

Further reading: choosing a skin science book

A good reference book makes this kind of note much easier to follow. Look for one that explains the stratum corneum, molecular size and vehicle effects with diagrams rather than slogans. When comparing titles, check four things: the author's field (cosmetic chemistry, pharmaceutics or skin biology), the publication date, whether chapters cite primary research, and whether the book separates laboratory data from human study outcomes.

Format and price are worth comparing too. Formulation-focused texts are often priced like textbooks, and a recent edition matters more in delivery science than in basic anatomy. Consumer-oriented label guides cost less and are quicker to read, but they usually skip permeation methods. An e-book with a searchable index is handy for anyone looking up INCI names often.

Before choosing, read a sample chapter where possible. A strong book states its uncertainties openly and shows its references. A weaker one leans on brand stories and before-and-after photos.

Indie formulators may want two books: one on skin barrier biology and one on emulsion and vehicle chemistry. Enthusiasts and estheticians are often well served by a single, well-referenced general text that they will actually return to.

Frequently asked questions

Do peptides penetrate skin at all?

Laboratory permeation research suggests some cosmetic peptides can enter the upper skin layers, with the amount depending strongly on the molecule and the formula [2][4]. Most cosmetic peptides are larger than the informal 500 Dalton guideline for easy passage through intact skin [1]. That makes broad claims of "deep penetration" hard to support without ingredient-specific data.

Does a positive human study prove a peptide penetrated the skin?

Not on its own. The 2005 palmitoyl pentapeptide-4 study reported differences in surface measures of fine lines and wrinkles versus vehicle [3]. It did not measure how deep the peptide went, and surface results and permeation data answer different questions.

Why do peptide names start with palmitoyl or acetyl?

These are chemical modifications, generally intended to make a peptide more stable or more compatible with the skin's lipid barrier. They also add mass, which moves the molecule further from the 500 Dalton guideline [1]. Each modified ingredient still needs its own permeation evidence.

Readers who want to know how we choose sources and how this site is funded can find details on our about page.

Last updated: 19 October 2026.

Related on this site

Not medical advice. This page reports published research and regulatory records for information only.

Research-only notice: Content on this site is provided for research and educational purposes only and is not intended for human use. It is not medical advice.

Translation notice: Some content on this site may have been machine-translated using Google Translate and may contain errors.

Sources

Prepared by

Research Desk